Generation of triple-knockout animals with a genetic deletion of both insulin receptor and IGF-1 receptor in addition to PHB2 (Phb2pko/Insrpko/Igf1rpko) significantly alleviated renal disease, enhanced survival (Fig4D and E), improved kidney function, and delayed the onset of kidney failure (Fig5A). This evidence concerns the gene PHB2 and kidney failure.